No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
Brenda Hermsen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Matti A. Rookus(The Netherlands Cancer Institute), Joanne A. de Hullu(Radboud University Nijmegen), Thea M. Mooij(The Netherlands Cancer Institute), Marc van Beurden(Oncode Institute), Leon F.A.G. Massuger(Radboud University Nijmegen), René H.M. Verheijen(Radboud University Nijmegen), Geertruida H. de Bock(University Medical Center Groningen), Curt W. Burger, Cecile T.M. Brekelmans(Erasmus MC), M J E Mourits(University Medical Center Groningen), Katja N. Gaarenstroom(Radboud University Nijmegen), R.I. Olivier(The Netherlands Cancer Institute), Hester H. van Boven(Leiden University)
Cited by 153
Related Papers
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|616
Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health‐related quality of life in breast cancer patients and survivors—a meta‐analysis
|Psycho-Oncology|2010|450
Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod
|New England Journal of Medicine|2008|397